---
figid: PMC4382495__12105_2015_619_Fig2_HTML
figlink: /pmc/articles/PMC4382495/figure/Fig2/
number: Fig. 2
caption: 'Signaling pathways involved in thyroid carcinogenesis and tumor progression.
  Growth factors induce receptor tyrosine kinase dimerization, resulting in tyrosine
  phosphorylation within the cytoplasmic tail, leading to RAS activation. Through
  the subsequent activation of BRAF and MEK, ERK is activated and translocates to
  the nucleus, where it activates various transcription factors. Similarly, the mTOR
  pathway is activated. In aggressive thyroid carcinomas, E-cadherin is down-regulated
  and β-catenin is stabilized and translocates to the nucleus; this and other epigenetic
  alterations can upregulate cyclin D1. Adhesion can be altered by multiple mechanisms,
  including adhesion molecules and growth factors, to impact tumor-stromal interactions.
  BRAF-like tumors show robust activation of MAPK signaling pathway, while RAS-like
  tumors activate both MAPK (to a lesser extent than BRAF-like tumors) and Akt-mTOR
  pathway, using p90RSK as a crucial cross-link to bcl-2 signaling []. Abbreviations:
  Akt protein kinase B, BAD bcl-2 associated death promoter, bcl-2 B cell lymphoma
  2, ERK extracellular-signal-related kinase, FGF fibroblast growth factor, FGFR FGF
  receptor, MEK mitogen activated protein kinase kinase, mTOR mechanistic target of
  rapamycin, RTK receptor tyrosine kinase, VEGF vascular endothelial growth factor,
  VEGFR VEGF receptor'
pmcid: PMC4382495
papertitle: 'When Thyroid Carcinoma Goes Bad: A Morphological and Molecular Analysis.'
reftext: Sylvia Papp, et al. Head Neck Pathol. 2015 Mar;9(1):16-23.
pmc_ranked_result_index: '123210'
pathway_score: 0.9262468
filename: 12105_2015_619_Fig2_HTML.jpg
figtitle: Signaling pathways involved in thyroid carcinogenesis and tumor progression
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4382495__12105_2015_619_Fig2_HTML.html
  '@type': Dataset
  description: 'Signaling pathways involved in thyroid carcinogenesis and tumor progression.
    Growth factors induce receptor tyrosine kinase dimerization, resulting in tyrosine
    phosphorylation within the cytoplasmic tail, leading to RAS activation. Through
    the subsequent activation of BRAF and MEK, ERK is activated and translocates to
    the nucleus, where it activates various transcription factors. Similarly, the
    mTOR pathway is activated. In aggressive thyroid carcinomas, E-cadherin is down-regulated
    and β-catenin is stabilized and translocates to the nucleus; this and other epigenetic
    alterations can upregulate cyclin D1. Adhesion can be altered by multiple mechanisms,
    including adhesion molecules and growth factors, to impact tumor-stromal interactions.
    BRAF-like tumors show robust activation of MAPK signaling pathway, while RAS-like
    tumors activate both MAPK (to a lesser extent than BRAF-like tumors) and Akt-mTOR
    pathway, using p90RSK as a crucial cross-link to bcl-2 signaling []. Abbreviations:
    Akt protein kinase B, BAD bcl-2 associated death promoter, bcl-2 B cell lymphoma
    2, ERK extracellular-signal-related kinase, FGF fibroblast growth factor, FGFR
    FGF receptor, MEK mitogen activated protein kinase kinase, mTOR mechanistic target
    of rapamycin, RTK receptor tyrosine kinase, VEGF vascular endothelial growth factor,
    VEGFR VEGF receptor'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - FGF19
  - MAPK3
  - AKT3
  - FGF4
  - FGF5
  - AKT2
  - KRAS
  - MAP2K2
  - MTOR
  - SART3
  - NRAS
  - CCND1
  - CDH1
  - MAPK1
  - FGF20
  - FGF21
  - FGFR2
  - FGFR4
  - FGF6
  - FGF7
  - BAD
  - CTNNB1
  - BCL2
  - BRAF
  - FLT1
  - FLT4
  - FGF13
  - FGF1
  - FGF2
  - HRAS
  - VEGFA
  - VEGFB
  - FGFR1
  - MAP2K1
  - FGF16
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF22
  - FGF14
  - FGFRL1
  - FGF3
  - FGF8
  - FGF23
  - PGF
  - FGFR3
  - VEGFD
  - VEGFC
  - KDR
  - FGF17
  - FGF18
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (cyclinD1)
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (VEGF)
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: (VEGF)
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: (VEGF)
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: (VEGF)
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: (VEGF)
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: 个FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
